Insider Transactions Reported by 18 Insiders of Syros Pharmaceuticals, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 05 Jan 2025

Syros Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
TIMOTHY TYSON Director $164,286 05 Jun 2024
Sue Gail Eckhardt Director $79,200 05 Jun 2024
WIRTH PETER Director $79,200 05 Jun 2024
ANDREW M. OH Director $79,200 05 Jun 2024
Marsha Fanucci Director $79,200 05 Jun 2024
Deborah Dunsire Director $79,200 05 Jun 2024
Gerald E. Quirk Chief Legal & Compliance Offic $33,524 19 Nov 2024
Eric R. Olson Chief Scientific Officer $29,442 17 Jul 2023
Mark J. Alles Director $28,045 16 Sep 2023
Richard A. Young Director $22,350 16 Sep 2024
SRINIVAS AKKARAJU Director $20,114 16 Sep 2024
Nancy A. Simonian Director $1,081 02 Dec 2024
David Roth Chief Medical Officer $0 18 Nov 2024
Kristin Stephens Chief Development Officer $0 18 Nov 2024
Jason Haas Chief Financial Officer $0 18 Nov 2024
Conley Chee President & CEO, Director $0 18 Nov 2024
SHARP PHILLIP A Director 01 Jun 2022
Amir Nashat Director 01 Jun 2022

Recent Insider Transactions by Companies or Individuals for Syros Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.